A science and technology advisory group has called on the Irish
government to ensure that the country remains competitive in the
pharmaceutical and chemical industries by developing R&D
operations and, in particular, fostering...
Reports in Ireland have suggested that Germany's Schwarz Pharma is
planning to scale back its operations in Shannon and cut its
workforce. The company is allegedly planning to reduce its Irish
workforce by 70 to around 180 staff.
US biopharmaceutical firm Acceptys has licensed an immortal
humanised cell line from Columbia University, which will allow it
to discover and produce fully human monoclonal antibodies and other
human proteins for use as therapeutic...
The German state of Saxony has implemented a $230 million,
five-year investment programme in a bid to nurture the development
of 'biosaxony,' centring on the establishment of regional
biotechnology hot spots in Leipzig and...
Belgian pharmaceutical and chemicals firm Solvay expects to launch
a new version of its Influvac brand flu vaccine, based on a novel
cell-based production process, in 2005. The speed of the new
process means that a vaccine can be...
BASF AG's Fine Chemicals division is expanding production of
pharmaceutical active ingredients with the construction of a new
plant at its site in Minden, Germany. A spokesman for the company
told In-pharmatechnologist.com that...
"Tremendous advances in science and technology, along with the
shrinking period for patent exclusivity, are creating unprecedented
opportunities for the drug development industry," said a CEO
this week while discussing the...
An international conference serving global centres of excellence
for biotechnology, so-called 'bio-technopoles,' life science parks
and 'bio-incubators' will take place ahead of the 7th European
BASF Plant Science, the plant biotechnology subsidiary of chemical
giant BASF, has entered into an agreement with Cellectis,
specialists in genome engineering and a recent spin-off from the
Institut Pasteur, that will provide BASF...
An EU funded project is building the critical mass of knowledge
required to ensure that Europe meets the Lisbon objective of
becoming the world's most competitive knowledge-based economy by
2010, reports Cordis.